Position: Home > Experts

Liang Yingmin

Author:admin      Time:2021-11-26     Number :179

Liang Yingmin
Dean of Hematology Hospital
Doctor of Medicine, Doctoral Supervisor, Chief Physician, Professor
Former Director of the Department of Hematology, Tangdu Hospital, Fourth Military Medical University
Standing Committee Member of the Hematology Physician Branch of the Chinese Medical Doctor Association
Standing Committee Member of the Association of Hematologists on Both Sides of the Taiwan Strait
Standing Committee Member of the Hematology Branch of the China Association for the Promotion of International Health Care
Chairman of the Hematology Professional Committee of Shaanxi Provincial Health Society
Chairman of the Clinical Immunology Branch of Shaanxi Medical Association
Honorary Chairman of the Hematology Society of Shaanxi Medical Association
Honorary Chairman of Shaanxi Anticancer Association Hematopoietic Stem Cell Transplant Society
Served as a standing committee member of the Hematology Branch of the Chinese Medical Association
Chairman of the Hematology Branch of Shaanxi Medical Association
Executive director and director of Shaanxi Medical Association
Undertook more than 10 national 863 key projects, national 863 program sub-projects and National Science Fund; published more than 150 papers, more than 50 SCI articles; participated in editing 2 textbooks; won 1 second prize of military medical achievement, Shaanxi Province Science There are 2 first prizes for technology, 1 third prize for Chinese Medical Science and Technology, 1 second prize for science and technology of China Anti-Cancer Association, 1 prize for education of talents and 1 silver prize for Chinese People’s Liberation Army academies. Cultivate 18 master and doctoral students.
He has long been engaged in clinical scientific research and teaching of hematological diseases, and has accumulated rich experience in the diagnosis and treatment of leukemia, lymphoma, myeloma and various difficult hematological diseases. Organized and carried out the first non-myeloablative hematopoietic stem cell transplantation and haploidentical hematopoietic stem cell transplantation in Northwest China Transplantation, and for the first time in China, the strategy of targeted therapy combined with bone marrow transplantation for the treatment of advanced chronic particles was proposed, which overcomes the "forbidden area" that is difficult to transplant for advanced chronic particles.